Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V W Rahlfs

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Deutsche Medizinische Wochenschrift (1946)|June 18, 1976
[Letter: Clofibrate and clofibrate-inositolnicotinate]V W Rahlfs
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
Operationalization of clinical study objectives: a precondition for demonstrating efficacyV W Rahlfs
Methods of Information in Medicine|April 1, 1973
[Testing partial contingency using linear models]V W Rahlfs
Fortschritte Der Medizin|August 16, 1973
[Possibilities and limitations in the objectivization of the therapeutic effect]V W Rahlfs
Journal of the American Academy of Dermatology|November 21, 1997
Understanding and evaluating clinical trialsV W Rahlfs
Controlled Clinical Trials|May 15, 2001
Testing two endpoints with control of the global alpha levelV W Rahlfs
International Journal of Clinical Practice|April 16, 1998
New principles of biometry 'not being observed'V W Rahlfs
Arzneimittel-Forschung|February 1, 1995
Conventional statistics and useful statisticsV W Rahlfs
Journal of Biopharmaceutical Statistics|July 1, 1997
Directional efficient tests or classic alpha adjustments?V W Rahlfs
Internationale Zeitschrift Fur Klinische Pharmakologie, Therapie, Und Toxikologie. International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1971
[Biometry and clinical pharmacological research]V W Rahlfs
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Deutsche Medizinische Wochenschrift (1946)|June 18, 1976
[Letter: Clofibrate and clofibrate-inositolnicotinate]V W Rahlfs
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
Operationalization of clinical study objectives: a precondition for demonstrating efficacyV W Rahlfs
Methods of Information in Medicine|April 1, 1973
[Testing partial contingency using linear models]V W Rahlfs
Fortschritte Der Medizin|August 16, 1973
[Possibilities and limitations in the objectivization of the therapeutic effect]V W Rahlfs
Journal of the American Academy of Dermatology|November 21, 1997
Understanding and evaluating clinical trialsV W Rahlfs
Controlled Clinical Trials|May 15, 2001
Testing two endpoints with control of the global alpha levelV W Rahlfs
International Journal of Clinical Practice|April 16, 1998
New principles of biometry 'not being observed'V W Rahlfs
Arzneimittel-Forschung|February 1, 1995
Conventional statistics and useful statisticsV W Rahlfs
Journal of Biopharmaceutical Statistics|July 1, 1997
Directional efficient tests or classic alpha adjustments?V W Rahlfs
Internationale Zeitschrift Fur Klinische Pharmakologie, Therapie, Und Toxikologie. International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1971
[Biometry and clinical pharmacological research]V W Rahlfs
Pageof 5